Author

William D. Chey 1

1 University of Michigan, Ann Arbor, United States of America

1-MONTH TREATMENT WITH ELUXADOLINE FOR IBS-D PREDICTS SUSTAINED RESPONSE: CONTINUATION ANALYSES OF RESPONSE IN TWO PHASE 3 STUDIES

William D. Chey, David A. Andrae, Leonard S. Dove, Catherine R. Gutman, Paul S. Covington

A SYSTEMATIC REVIEW AND META-ANALYSIS TO DETERMINE WHETHER BALLOON EXPULSION TESTING MIGHT BE AN APPROPRIATE INITIAL OFFICE-BASED TEST FOR DYSSYNERGIC DEFECATION

Eric Dinesh Shah, Jeremy Farida, William D. Chey

Bringing guidelines into clinical practice: Pharmacological agents

William D. Chey

EFFICACY OF NALOXEGOL IN A SUBPOPULATION OF PATIENTS WITH OPIOID-INDUCED CONSTIPATION AND AN INADEQUATE BASELINE RESPONSE TO LAXATIVES: RESULTS FROM 2 PROSPECTIVE, RANDOMIZED, CONTROLLED TRIALS

Jan Tack, William D. Chey, Lynn Webster, Mark Sostek, Peter N Barker, Jaakko Lappalainen

ELUXADOLINE DEMONSTRATES SUSTAINED EFFICACY FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHOEA IN PHASE 3 CLINICAL TRIALS

William D. Chey, Leonard S. Dove, David A. Andrae, J. Michael Davenport, Lisa Turner, Rocio Lopez, Paul S. Covington

HIGH DISCOVERY RATE OF EOSINOPHILIC GASTRITIS AND/OR DUODENITIS AMONG PATIENTS WITH CHRONIC FUNCTIONAL GASTROINTESTINAL SYMPTOMS

Amol Kamboj, Nicholas J. Talley, William Chey, Henrik Rasmussen, Kathryn Peterson, Mirna Chehade, Brian Lacy, Ikuo Hirano, Anthony J. Lembo, Colleen Schmitt, Marc E. Rothenberg, Robert Genta, Neal Jain, Maria Pletneva, Cory Mekelburg, Evan S. Dellon, William J. Sandborn, Nirmala Gonsalves, Kevin Turner, Malika Pasha

HOW COST AFFECTS THE TREATMENT CHOICE FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA PATIENTS: A COST-EFFECTIVENESS ANALYSIS OF TRICYCLIC AGENTS AND RIFAXIMIN

Eric Dinesh Shah, Elizabeth Andraska, Jonathan Li, Sai Zhang, William D. Chey

IS RESPONSE TO LINACLOTIDE AFTER 4 WEEKS OF TREATMENT PREDICTIVE OF 12-WEEK IMPROVEMENT?

William D. Chey, Bernard Lavins, Steven Shiff, Mark G. Currie, Steven Shiff, James MacDougall, Caroline B. Kurtz, Mark G. Currie, Jeffrey Johnston

Managing GI side effects of opioids

William D. Chey

NALOXEGOL SYMPTOM RESPONDER RATES IN PATIENTS WITH OPIOID-INDUCED CONSTIPATION: RESULTS FROM 2 PROSPECTIVE, RANDOMIZED, CONTROLLED TRIALS

Jan Tack, William D. Chey, Lynn Webster, Jaakko Lappalainen, Peter N Barker, Mark Sostek

Item 1 - 10 / 18
1
2